Treatment for Suspected Pulmonary Embolism

When a patient presents with risk factors for pulmonary embolism (PE) such as recent travel and oral contraceptive pill use, along with symptoms like tachypnea, tachycardia, and hypoxia, it is important to consider the possibility of a significant PE. In such cases, treatment with low molecular weight heparin should be given promptly to prevent further complications. A low-grade fever is also common in venothromboembolic disease. Elevated JVP signifies significant right heart strain due to a significant PE, but maintained blood pressure is a positive sign.

The most common ECG finding in PE is an isolated sinus tachycardia, while the CXR may be clear, but prominent pulmonary arteries reflect pulmonary hypertension due to clot load in the pulmonary tree. A D-dimer test is recommended if the Wells score for PE is less than 4.

According to NICE guidelines on venous thromboembolic diseases, low molecular weight heparin is the appropriate initial treatment for suspected PE. It is important not to delay treatment to await CTPA unless it can be performed immediately. There is no evidence of pneumonia to warrant IV antibiotics. Unfractionated heparin may be considered for patients with an eGFR of less than 30, high risk of bleeding, or those undergoing thrombolysis, but this is not the case with this patient. Thrombolysis is not indicated unless there is haemodynamic instability, even in suspected large PEs.

In summary, prompt treatment with low molecular weight heparin is crucial in suspected cases of PE, and other treatment options should be considered based on individual patient factors.

When a patient is in an upright position, the functional residual capacity (FRC) can increase due to less pressure from the diaphragm and abdominal organs on the lung bases. This increase in FRC can also be caused by emphysema and asthma. On the other hand, factors such as abdominal swelling, pulmonary edema, reduced muscle tone of the diaphragm, and aging can lead to a decrease in FRC. Additionally, laparoscopic surgery, obesity, and muscle relaxants can also contribute to a reduction in FRC.

Understanding Lung Volumes in Respiratory Physiology

In respiratory physiology, lung volumes can be measured to determine the amount of air that moves in and out of the lungs during breathing. The diagram above shows the different lung volumes that can be measured.

Tidal volume (TV) refers to the amount of air that is inspired or expired with each breath at rest. In males, the TV is 500ml while in females, it is 350ml.

Inspiratory reserve volume (IRV) is the maximum volume of air that can be inspired at the end of a normal tidal inspiration. The inspiratory capacity is the sum of TV and IRV. On the other hand, expiratory reserve volume (ERV) is the maximum volume of air that can be expired at the end of a normal tidal expiration.

Residual volume (RV) is the volume of air that remains in the lungs after maximal expiration. It increases with age and can be calculated by subtracting ERV from FRC. Speaking of FRC, it is the volume in the lungs at the end-expiratory position and is equal to the sum of ERV and RV.

Vital capacity (VC) is the maximum volume of air that can be expired after a maximal inspiration. It decreases with age and can be calculated by adding inspiratory capacity and ERV. Lastly, total lung capacity (TLC) is the sum of vital capacity and residual volume.

Physiological dead space (VD) is calculated by multiplying tidal volume by the difference between arterial carbon dioxide pressure (PaCO2) and end-tidal carbon dioxide pressure (PeCO2) and then dividing the result by PaCO2.

The trachea starts at the sixth cervical vertebrae and ends at the fifth thoracic vertebrae (or sixth in individuals with a tall stature during deep inhalation).

Anatomy of the Trachea

The trachea, also known as the windpipe, is a tube-like structure that extends from the C6 vertebrae to the upper border of the T5 vertebrae where it bifurcates into the left and right bronchi. It is supplied by the inferior thyroid arteries and the thyroid venous plexus, and innervated by branches of the vagus, sympathetic, and recurrent nerves.

In the neck, the trachea is anterior to the isthmus of the thyroid gland, inferior thyroid veins, and anastomosing branches between the anterior jugular veins. It is also surrounded by the sternothyroid, sternohyoid, and cervical fascia. Posteriorly, it is related to the esophagus, while laterally, it is in close proximity to the common carotid arteries, right and left lobes of the thyroid gland, inferior thyroid arteries, and recurrent laryngeal nerves.

In the thorax, the trachea is anterior to the manubrium, the remains of the thymus, the aortic arch, left common carotid arteries, and the deep cardiac plexus. Laterally, it is related to the pleura and right vagus on the right side, and the left recurrent nerve, aortic arch, and left common carotid and subclavian arteries on the left side.

Overall, understanding the anatomy of the trachea is important for various medical procedures and interventions, such as intubation and tracheostomy.

Noisy Breathing and Atopy in Adolescents

The presence of noisy breathing in an adolescent may indicate the possibility of stridor, which can be caused by an allergic reaction even in an otherwise healthy individual. The history of atopy, or a tendency to develop allergic reactions, further supports the diagnosis of angio-oedema. The sudden onset of symptoms also adds to the likelihood of this diagnosis.

While asthma is a possible differential diagnosis, it typically presents with expiratory wheezing. However, if the chest is silent, it may indicate a severe and life-threatening form of asthma. Therefore, it is important to consider all possible causes of noisy breathing and atopy in adolescents to ensure prompt and appropriate treatment.

Prochlorperazine belongs to a class of drugs known as dopamine receptor antagonists, which work by inhibiting stimulation of the chemoreceptor trigger zone (CTZ) through D2 receptors. Other drugs in this class include domperidone, metoclopramide, and olanzapine.

Antihistamine antiemetics, such as cyclizine and promethazine, are H1 histamine receptor antagonists.

5-HT3 receptor antagonists, such as ondansetron and granisetron, are effective both centrally and peripherally. They work by blocking serotonin receptors in the central nervous system and gastrointestinal tract.

Antimuscarinic antiemetics are anticholinergic drugs, with hyoscine (scopolamine) being a common example.

Vertigo is a condition characterized by a false sensation of movement in the body or environment. There are various causes of vertigo, each with its own unique characteristics. Viral labyrinthitis, for example, is typically associated with a recent viral infection, sudden onset, nausea and vomiting, and possible hearing loss. Vestibular neuronitis, on the other hand, is characterized by recurrent vertigo attacks lasting hours or days, but with no hearing loss. Benign paroxysmal positional vertigo is triggered by changes in head position and lasts for only a few seconds. Meniere’s disease, meanwhile, is associated with hearing loss, tinnitus, and a feeling of fullness or pressure in the ears. Elderly patients with vertigo may be experiencing vertebrobasilar ischaemia, which is accompanied by dizziness upon neck extension. Acoustic neuroma, which is associated with hearing loss, vertigo, and tinnitus, is also a possible cause of vertigo. Other causes include posterior circulation stroke, trauma, multiple sclerosis, and ototoxicity from medications like gentamicin.

Acute Treatment of Asthma

When dealing with acute asthma, the initial approach should be SOS, which stands for Salbutamol, Oxygen, and Steroids (IV). It is also important to organize a CXR to rule out pneumothorax. If the patient is experiencing bronchoconstriction, further efforts to treat it should be considered. If the patient is tiring or has a silent chest, ITU review may be necessary. Magnesium is recommended at a dose of 2 g over 30 minutes to promote bronchodilation, as low magnesium levels in bronchial smooth muscle can favor bronchoconstriction. IV theophylline may also be considered, but magnesium is typically preferred. While IV antibiotics may be necessary, promoting bronchodilation should be the initial focus. IV potassium may also be required as beta agonists can push down potassium levels. Oral prednisolone can wait, as IV hydrocortisone is already part of the SOS approach. Non-invasive ventilation is not recommended for the acute management of asthma.

Identify the life-threatening features of an asthma attack.

Assessing the severity of asthma attacks in children is crucial for effective management. The 2016 BTS/SIGN guidelines provide criteria for assessing the severity of asthma in general practice. These criteria include measuring SpO2 levels, PEF (peak expiratory flow) rates, heart rate, respiratory rate, use of accessory neck muscles, and other symptoms such as breathlessness, agitation, altered consciousness, and cyanosis.

A severe asthma attack is characterized by a SpO2 level below 92%, PEF rates between 33-50% of the best or predicted, being too breathless to talk or feed, and a high heart and respiratory rate. On the other hand, a life-threatening asthma attack is indicated by a SpO2 level below 92%, PEF rates below 33% of the best or predicted, a silent chest, poor respiratory effort, use of accessory neck muscles, agitation, altered consciousness, and cyanosis.

It is important for healthcare professionals to be familiar with these criteria to ensure prompt and appropriate management of asthma attacks in children. Early recognition of the severity of an asthma attack can help prevent complications and reduce the risk of hospitalization or death.

When hypoxia is present, the pulmonary arteries undergo vasoconstriction, which is the appropriate response. The patient is exhibiting symptoms of pneumonia and type 1 respiratory failure, as evidenced by clinical and radiographic findings. Vasoconstriction of the small pulmonary arteries helps to redirect blood flow from poorly ventilated regions of the lung to those with better ventilation, resulting in improved gas exchange efficiency between the alveoli and blood.

The Effects of Hypoxia on Pulmonary Arteries

When the partial pressure of oxygen in the blood decreases, the pulmonary arteries undergo vasoconstriction. This means that the blood vessels narrow, allowing blood to be redirected to areas of the lung that are better aerated. This response is a natural mechanism that helps to improve the efficiency of gaseous exchange in the lungs. By diverting blood to areas with more oxygen, the body can ensure that the tissues receive the oxygen they need to function properly. Overall, hypoxia triggers a physiological response that helps to maintain homeostasis in the body.

The patient’s blood gas analysis shows a lower oxygen pressure by about 10kPa than the percentage of oxygen. The PaCo2 level is 3.5, indicating respiratory alkalosis or compensation for metabolic acidosis. The HCO3- level is 18.6, which suggests metabolic acidosis or metabolic compensation for respiratory alkalosis. These results indicate that the patient has metabolic acidosis with complete respiratory compensation. Additionally, the patient’s high blood glucose level suggests that the metabolic acidosis is due to diabetic ketoacidosis.

Arterial Blood Gas Interpretation: A 5-Step Approach

Arterial blood gas interpretation is a crucial aspect of patient care, particularly in critical care settings. The Resuscitation Council (UK) recommends a 5-step approach to interpreting arterial blood gas results. The first step is to assess the patient’s overall condition. The second step is to determine if the patient is hypoxaemic, with a PaO2 on air of less than 10 kPa. The third step is to assess if the patient is acidaemic (pH <7.35) or alkalaemic (pH >7.45).

The fourth step is to evaluate the respiratory component of the arterial blood gas results. A PaCO2 level greater than 6.0 kPa suggests respiratory acidosis, while a PaCO2 level less than 4.7 kPa suggests respiratory alkalosis. The fifth step is to assess the metabolic component of the arterial blood gas results. A bicarbonate level less than 22 mmol/l or a base excess less than -2mmol/l suggests metabolic acidosis, while a bicarbonate level greater than 26 mmol/l or a base excess greater than +2mmol/l suggests metabolic alkalosis.

To remember the relationship between pH, PaCO2, and bicarbonate, the acronym ROME can be used. Respiratory acidosis or alkalosis is opposite to the pH level, while metabolic acidosis or alkalosis is equal to the pH level. This 5-step approach and the ROME acronym can aid healthcare professionals in interpreting arterial blood gas results accurately and efficiently.

Glomerulonephritis is a condition that affects the kidneys and can present with various pathological changes. In rapidly progressive glomerulonephritis, patients may present with respiratory tract symptoms and cutaneous manifestations of vasculitis. Renal biopsy will show epithelial crescents in Bowman’s capsule, indicating severe glomerular injury. Mesangioproliferative glomerulonephritis is characterized by a diffuse increase in mesangial cells and is not associated with respiratory tract symptoms or cutaneous manifestations of vasculitis. Membranoproliferative glomerulonephritis involves deposits in the intraglomerular mesangium and is associated with activation of the complement pathway and glomerular damage. It is unlikely to be the diagnosis in the scenario as it is not associated with vasculitis symptoms. A normal nephron architecture would not explain the patient’s symptoms and is an incorrect answer.

Granulomatosis with Polyangiitis: An Autoimmune Condition

Granulomatosis with polyangiitis, previously known as Wegener’s granulomatosis, is an autoimmune condition that affects the upper and lower respiratory tract as well as the kidneys. It is characterized by a necrotizing granulomatous vasculitis. The condition presents with various symptoms such as epistaxis, sinusitis, nasal crusting, dyspnoea, haemoptysis, and rapidly progressive glomerulonephritis. Other symptoms include a saddle-shape nose deformity, vasculitic rash, eye involvement, and cranial nerve lesions.

To diagnose granulomatosis with polyangiitis, doctors perform various investigations such as cANCA and pANCA tests, chest x-rays, and renal biopsies. The cANCA test is positive in more than 90% of cases, while the pANCA test is positive in 25% of cases. Chest x-rays show a wide variety of presentations, including cavitating lesions. Renal biopsies reveal epithelial crescents in Bowman’s capsule.

The management of granulomatosis with polyangiitis involves the use of steroids, cyclophosphamide, and plasma exchange. Cyclophosphamide has a 90% response rate. The median survival rate for patients with this condition is 8-9 years.